was not isolated in the treated culture.
Despite the availability of antimicrobial drugs, the mortality rate from bacteremia remains high. The identification and susceptibility of the infecting organism should be determined as early as possible in the course of bacteremia, since the early administration of the appropriate antibiotic greatly improves the chances of survival of the patient (5) . However, rapid isolation of the offending organisms from bacteremic patients may be difficult when the patient has been administered antibiotics, which are transferred along with the bacteria in the blood into the culture broths and often inhibit the growth of the agent (1, 2, 4) . Natural opsonins, beta-lysins, and other inhibitors in blood also suppress bacterial growth in cultures.
Recently, Melnick and Wallis (J. L. Melnick and C. Wallis, U.S. Patent 4,145,304, 1979) developed a method for the removal of antibiotics and other bacterial inhibitors from whole blood without significantly decreasing the bacterial titer. They designed a mixed-resin system called the Antimicrobial Removal Device (ARD), which efficiently removes antibiotics and some bacterial inhibitors from whole blood after tumbling the mixture under specific conditions. The current report is concerned with the clinical application of the ARD as compared to conventional blood culturing to determine its efficacy in isolating bacteria from septicemic patients.
MATERIALS AND METHODS
ARD. ARDs were provided by Marion Laboratories Inc., Kansas City, Mo. Preparation of these devices has been described in detail (Melnick and Wallis, U.S. Patent 4, 145, 304, 1979) . In brief, the ARD consists of a 60-ml rubber-capped vial loaded with 10 g of cationic resin (C249-Ionac, Birmingham, N.J.) and 15 g of polymeric adsorbant resin (Amberlite XAD4, Rohm & Haas, Philadelphia, Pa.), which have been pretreated to prevent bacterial retention. The 25 g of mixed resin is fluidized with 5 ml of physiological saline. The inner portion of the rubber cap used to seal the ARD is equipped with a filter guard that prevents resin from entering the needle when fluids are removed from the device. The sealed device is then sterilized by autoclaving. The complete ARD bottle is available from Marion Laboratories (Kansas City, Mo.). For use, 5 to 10 ml of whole blood is aseptically injected into the ARD, which is then placed on a tumbler (Applied Poly-Technology, Inc., Houston, Tex.) specifically designed for rotating the ARD on its axis at 84 rpm. This rotation maintains the resin in suspension for maximum removal of antibiotics. After 15 min of tumbling, the ARD is removed from the tumbler, and the blood-saline mixture is aseptically withdrawn and transferred to a standard blood culture broth.
Patients. The patients in this study had a history of recent or current antibiotic therapy and were thought to be septicemic. Antibiotic blood levels were taken from the hospital record. Blood cultures had been ordered on all patients by their physicians as an aid to diagnosis.
Blood cultures and experimental procedures. Blood in 15-ml samples was aseptically collected by syringe. One 5-ml sample (the first) was transferred to a blood culture broth (Lederle), and was examined according to routine hospital practice. Another 5-ml sample (the second) was added to a duplicate blood culture broth, from which samples were later subcultured as indicated. The last 5-ml sample (the third) was inoculated into the ARD at bedside and immediately taken to the laboratory, where it was tumbled for 15 min. The supernatant mixture of the third bottle was then aspirated and aseptically transferred to a standard blood culture broth. The three blood cultures from the same patient were then incubated at 35°C, with subcultures performed from the second and third bottles at 3, 8, 24, 48, and 72 h and at 7 days. The experimental procedures and results on the samples used for the second and third cultures had no influence on patient therapy. Our study compares the ability and time to isolate organisms in the second (standard) and third (ARD) blood culture broths.
RESULTS
Fifty-one patients were evaluated, of whom 31 proved to be bacteremic. Earlier isolation of bacteria from blood occurred in 21 of the matched cultures when the blood was first processed by the ARD as compared to standard cultures. In four instances, bacteria were recovered only from the ARD-processed samples, whereas only once was the infectious agent recovered only in the standard culture.
As noted in Table 1 , 13 positive subcultures were obtained when planted within the first 12 h after the ARD treatment, but only 2 were obtained by the standard blood culture method within the same time period. The three cases that were positive by subculture after 7 days of incubation in the standard culture group were organisms (two Staphylococcus aureus and one Bacteroides strains) that would have been expected to grow readily in the culture broth before the 7-day period. However, the high concen- 304, 1979) , and all, up to 100 ,ug, were found to be rapidly and completely removed from the blood by the ARD and tumbler described in the present paper. In the clinical study reported here, the device performed well; earlier isolation was found in 21 of 30 patients, and in 4 patients isolation occurred only with ARD-processed blood. In only one instance was a blood culture positive with standard technique and not in the ARD-processed blood.
The positive results of this study agree with a subsequent study on Staphylococcus endocarditis, which showed that in 47 cultures from patients on antibiotic therapy, 4 were positive both by standard blood culturing and after ARD treatment, but 22 were positive only when the blood was processed by the ARD (J. A. Washington II, Mayo Clinic, personal communication).
The separation of bacteria from antibiotics in blood by membrane filtration (5) is time consuming, and the manipulations seem conducive for contamination. Higher efficiency ofisolations should be achieved by using the ARD in conjunction with the BACTEC system (3). The uptake of radioactive materials in this test by bacteria is also delayed by the presence of antibiotics in blood, since metabolism of labeled dextrose or amino acids is inhibited when bacteria are not biosynthetically active. Thus, the use of the ARD should enhance the ability and time of diagnosis of septicemia by BACTEC as well as by standard methods.
